The new Eluxeo 8000® endoscopy system
Image source: Fujifilm Healthcare Europe
News • European system launch
Fujifilm welcomes the future of endoscopy
The Fujifilm Healthcare Europe Team are excited to announce the European launch of Eluxeo 8000®, a new advanced endoscopy system with new therapeutic capabilities, workflow management and improved image quality.
This is the first of an entire series of new and upcoming innovations to be released under the company's new ‘Welcome, Future’ initiative. "We are delighted to announce the release of our new endoscopy platform and series of innovations to support the important work of endoscopists across Europe. We look forward to receiving valuable feedback from our customers as we work together to strengthen the future of endoscopy technology,” says Takemasa Kojima, Managing Director of Fujifilm Healthcare Europe.
The ACI is even more important in this situation because it's emphasising the details and the contrast between mucosa, submucosa, muscle, and also allowing a very nice enhancement of the vessels... thanks to this feature of ACI, it’s very relevant from a clinical standpoint, from the outcome, and from the safety standpoint
Alessandro Repici
Looking back on almost a century of engineering, craftsmanship and imaging heritage, the company will, across the next two years, showcase their new series of technologies designed to expand the possibilities of endoscopy.
Pioneering the new initiative, the Eluxeo® 8000 system aims to advance treatment scenarios with features such as the new ACI mode (Amber-Red Color Imaging), which not only supports the detection of bleeding sources, but can also be beneficial during minimally invasive third-space endoscopy treatment. While studies on this technology are still in progress with the endoscopy community, initial feedback from international experts has suggested that the ACI mode provides improved visibility of the different layers during procedures and could therefore help endoscopists to prevent bleeding, the company reports.
Fujifilm cites several endoscopists across Europe who had a chance to work with the new system to attest to its capabilities: "I think using (ACI) to identify the muscle versus submucosal plane keeps you in the right plane all along and makes your ESD safer and quicker,” says Professor Pradeep Bhandari MBBS, MD, DRCP, Professor of Gastroenterology at the Portsmouth Hospitals University NHS Trust. "This will reduce the learning curve of beginners and make ESD more widely available.”
Professor Alessandro Repici, Director of Digestive Endoscopy Dept at Humanitas Research Hospital, Milano, Italy, adds: “ACI is a significant step ahead in the features that are provided by Fujifilm endoscopes. It's very useful not only for the third space but in general for advanced therapeutic procedures... And the ACI is even more important in this situation because it's emphasising the details and the contrast between mucosa, submucosa, muscle, and also allowing a very nice enhancement of the vessels... thanks to this feature of ACI, it’s very relevant from a clinical standpoint, from the outcome, and from the safety standpoint.”
“The addition of ACI, I think, is key for therapeutics because it allows people, even those who are experienced at, for example, tissue resection, ESD, to perform the procedure, I would say, quicker with a similar safety profile due to the optical characteristics of being able to recognize the plane better and deal prophylactically with bleeding,” reports Dr. David J. Tate MA, MBBS, MRCP, Interventional Endoscopist and Gastroenterologist at Ghent University Hospital, Belgium.
With a focus on workflow efficiency, the Eluxeo® 8000 is designed to support physicians with a simpler, more productive, day-to-day clinical workflow, Fujifilm points out. The workflow management tools included in the new solution aim to deliver improved usability with connected systems and data integration. For example, during procedures, this could mean preventing accidental double insufflation of air and CO2* or enabling water irrigation with the touch of a button.
The company further highlights an optional 15-inch touch screen tablet with a user-friendly interface, a new addition in this release designed to enable a more intuitive way of operating the processor. Using this solution, physicians can record DICOM-compatible images and videos for documentation purposes. Continued development for this product has been planned by Fujifilm to further enhance connectivity and the ability to collate intelligent information.
Taking inspiration from the alternative imaging areas of x-ray and ultrasound, the Eluxeo® 8000 system utilizes the company's triple noise reduction technology (3NR) from combined imaging specialities with extended dynamic range, to improve sharpness and enhanced brightness optimisation in both the near and far field. Together with their latest CMOS sensor and 4K output, the combination of the new system with the newly released 800 series endoscopes, Fujifilm is convinced this achieves their cleanest and brightest endoscopic image yet.
“The Eluxeo 8000® series is a tremendous new processor that not only brings better imaging, tailor-made for enhanced diagnostics including state-of-the-art linked colour imaging and blue light imaging, tried and tested both for detection and characterisation; but also, lends itself extremely well to very high definition 4K imaging using CMOS chips and the most impressive ACI designed for third space endoscopy,” concludes Prof. Edward John Despott MD FRCP FJGES MD(Res), Consultant Interventional Endoscopist and Gastroenterologist at the Royal Free London and The Wellington Hospital.
* This feature requires the MDR certified GW-100 CO2 Insufflator.
Source: Fujifilm Healthcare Europe
03.04.2025
